# NCI Moonshot: Accelerate Cervical Cancer Control

> **NIH NIH N01** · LEIDOS BIOMEDICAL RESEARCH, INC. · 2024 · $3,000,000

## Abstract

DCEG is conducting an NCI-Moonshot funded project to "Accelerate Cervical Cancer Control”. This project includes the development of new technologies for cervical cancer screening that can be implemented in high- and low-resource settings. Two important areas related to the Moonshot project will be conducted in the HPV Genomics Unit of CGR: One, HPV genotyping for a large number (over 200,000) of clinical specimens from various Moonshot-related studies, from both high- and low-resource settings. Two, development support to perform routine testing of host and viral methylation assays for cervical cancer screening for a large number (over 50,000) of clinical specimens from both high- and low-resource settings. DCEG is requesting additional laboratory support to supplement existing resources within the HPV Genomics Unit of CGR.

## Key facts

- **NIH application ID:** 11042043
- **Project number:** 75N91019D00024-P00021-759101900134-1
- **Recipient organization:** LEIDOS BIOMEDICAL RESEARCH, INC.
- **Principal Investigator:** LEONARD FREEDMAN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $3,000,000
- **Award type:** —
- **Project period:** 2019-08-31 → 2026-08-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11042043

## Citation

> US National Institutes of Health, RePORTER application 11042043, NCI Moonshot: Accelerate Cervical Cancer Control (75N91019D00024-P00021-759101900134-1). Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/grant/nih/11042043. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*